Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Pfizer Inc. (NYSE: PFE ) is included among the 14 Best Dividend Stocks to Invest in Under $50 Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline On March 2, Argus upgraded Pfizer Inc. (NYSE:PFE) to Buy from Hold. The firm set a $35 price target on the stock. Argus said it sees encouraging progress in the company's GLP-1 pipeline, along with what it described as “robust” programs in oncology and hematology. The analyst said these developments increase confidence in Pfizer's ability to grow both revenue and earnings in the period after 2028. Argus also pointed to the company's accelerated research and development efforts, the successful launch of new products, and additional bolt-on business development initiatives expected beyond that timeframe. Earlier, on February 24, Pfizer announced that the US Food and Drug Administration granted full approval to BRAFTOVI (encorafenib). The drug is used in combination with Erbitux (cetuximab) and fluorouracil-based
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- A Look At Pfizer (PFE) Valuation As Long Term Returns And DCF Views Diverge [Yahoo! Finance]Yahoo! Finance
- Pfizer: Obesity Hype And Vaccine Policy Shocks [Seeking Alpha]Seeking Alpha
- Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Moderna will pay up to $2.25B to end COVID vaccine patent fight [Yahoo! Finance]Yahoo! Finance
- ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 3/3/26 - Form 4
- 2/27/26 - Form 4
- 2/27/26 - Form 4
- PFE's page on the SEC website